Polimanti, Renato https://orcid.org/0000-0003-0745-6046
Levey, Daniel F. https://orcid.org/0000-0001-8431-9569
Pathak, Gita A.
Wendt, Frank R.
Nunez, Yaira Z.
Ursano, Robert J. https://orcid.org/0000-0002-1861-9173
Kessler, Ronald C. https://orcid.org/0000-0003-4831-2305
Kranzler, Henry R. https://orcid.org/0000-0002-1018-0450
Stein, Murray B. https://orcid.org/0000-0001-9564-2871
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
American Foundation for Suicide Prevention
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
Article History
Received: 10 March 2020
Revised: 27 November 2020
Accepted: 3 December 2020
First Online: 11 January 2021
Conflict of interest
: Dr. Kranzler is a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which for the past three years was supported by AbbVie, Alkermes, Amygdala Neurosciences, Arbor, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, and Pfizer. Dr. Kranzler is paid for his editorial work on the journal Alcoholism: Clinical and Experimental Research. Drs. Kranzler and Gelernter are named as inventors on PCT patent application #15/878,640 entitled: “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. In the past 3 years, Dr. Kessler was a consultant for Datastat, Inc, Sage Pharmaceuticals, and Takeda. Dr. Murray Stein is paid for his editorial work on the journals Biological Psychiatry and Depression and Anxiety, and the health professional reference Up-To-Date. Drs. Polimanti and Gelernter are paid for their editorial work on the journal Complex Psychiatry. The other authors declare no competing interests.